Press Releases
Recro Pharma to Participate in Upcoming Investor Conferences
Recro Pharma Provides Pipeline Update
Recro Pharma Appoints Karen A. Flynn to Its Board of Directors
Recro Pharma Announces Presentations at PAINWeek 2015
Recro Pharma Reports Second Quarter 2015 Financial Results
Recro Pharma Announces Additional Information for Phase II Clinical Trial of Dex-IN
Recro Pharma Appoints Scott Rizzo as General Manager
Recro Pharma Announces Positive Top-Line Results for Phase II Clinical Trial of Dex-IN
Recro Pharma Completes $16 Million Private Financing
